Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Q4 2025 value amounting to 0.73.

  • Arrowhead Pharmaceuticals' Asset Utilization Ratio rose 3133592.01% to 0.73 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.73, marking a year-over-year increase of 3133592.01%. This contributed to the annual value of 0.66 for FY2025, which is 1752528.31% up from last year.
  • Latest data reveals that Arrowhead Pharmaceuticals reported Asset Utilization Ratio of 0.73 as of Q4 2025, which was up 3133592.01% from 0.6 recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.73 in Q4 2025 and a low of 0.0 during Q4 2024
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.3 (2023), whereas its average is 0.28.
  • In the last 5 years, Arrowhead Pharmaceuticals' Asset Utilization Ratio tumbled by 9911.09% in 2024 and then surged by 3133592.01% in 2025.
  • Arrowhead Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then surged by 64.15% to 0.35 in 2022, then decreased by 25.72% to 0.26 in 2023, then tumbled by 99.11% to 0.0 in 2024, then skyrocketed by 31335.92% to 0.73 in 2025.
  • Its Asset Utilization Ratio was 0.73 in Q4 2025, compared to 0.6 in Q3 2025 and 0.39 in Q2 2025.